We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

2 FTSE 100 stocks I’d buy today and hold forever in a Stocks and Shares ISA

These two FTSE 100 (INDEXFTSE:UKX) shares could offer high long-term returns, in my opinion.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 may be facing a period of uncertainty, due to risks such as coronavirus and geopolitical uncertainty in the US and Europe. However, there are a number of large-cap shares which appear to offer good value for money at present, due to their long-term growth potential.

With that in mind, here are two stocks that could be worth buying today through a tax-efficient account such as a Stocks and Shares ISA. They appear to have favourable long-term operating environments which may catalyse their financial performances in the coming years.

XXX

GSK

The next couple of years will be a period of significant change for GSK (LSE: GSK). Its separation into two companies could create a degree of uncertainty, which may cause investor sentiment to weaken. However, the end result is set to be a more focused biopharma company, as well as a leader in consumer healthcare.

The long-term growth potential for both businesses appears to be high. A growing, ageing world population could provide rising demand for a wide range of healthcare products. This could help to stimulate the company’s bottom line following its relatively lacklustre 1% rise in earnings in the 2020 financial year.

The stock’s price-to-earnings (P/E) ratio of 14.6 suggests it currently offers a wide margin of safety. Alongside its dividend yield of 4.6%, the company could offer the chance for investors to generate improving total returns – especially as it has the potential to become leaner and more focused as two companies. As such, now could be the right time to buy a slice of the business while it appears to offer good value for money.

Segro

Another FTSE 100 company which could have a bright long-term future is real estate investment trust (REIT) Segro (LSE: SGRO). It owns a range of warehouses across the UK and Europe which have experienced high demand from online retailers in recent years.

That trend looks set to continue, with suitable large warehouses seemingly in short supply. Segro reported in its recent quarterly update that demand for its properties has been high, and that rental growth has been buoyant. This could contribute to rising profitability over the long run, while over the next two years it’s expected to post an increase in its net profit of 8% per annum.

Segro’s price-to-book (P/B) ratio of 1.5 may be substantially higher than many of its REIT sector peers. However, its stronger financial prospects and the high demand for its properties means is could be worthy of a premium valuation. The long-term growth potential of online retailing suggests further share price growth could be ahead for the company following its 40% rise over the past year.

As such, buying it today, and holding it for the long run, could be a shrewd move.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »